Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) surges over 2%, focusing on Hong Kong-listed biotech companies.
the Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) staged a strong morning session. As of 10:05, the fund had jumped more than 2%, extending its five-day gain to 8.35%. It is now on track for a fourth consecutive daily advance.
NewTimeSpace News: Wind data shows that on January 7, the Chinaamc Hang Seng Hong Kong Biotech Index
ETF(03069.HK) staged a strong morning session. As of 10:05, the fund had jumped more than 2%, extending its five-day gain to 8.35%. It is now on track for a fourth consecutive daily advance.
According to HKEX data, CSIF Heng Seng Biotech (03069.HK) is an ETF issued by China Asset Management (Hong Kong) Limited that tracks the Hang Seng Hong Kong-Listed Biotech Index. The fund zeroes in on the leading biotech names listed in Hong Kong, offering high beta and high volatility—an ideal vehicle for investors bullish on innovative drugs, CXOs, vaccines, gene therapy and related niches.
As the first ETF in Hong Kong to track the Hang Seng Hong Kong-Listed Biotech Index, it enjoys first-mover advantage and fills a gap in the local market. Within the biotech space—especially for Hong Kong-listed biotech companies—the product remains both unique and scarce.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
Tags：
- After sliding for several consecutive sessions, Samsung CSI China Dragon Internet ETF (02812.HK) dropped 2.84%.
- Shaken in early trade, Pando Ethereum ETF (03085.HK) slid nearly 3%, though the fund still shows a year-to-date gain of roughly 10%.
- Phillip Hk Newly Listed Equities Index Etf (02835.HK) surged nearly 2% in the morning session; the fund offers investors a passive vehicle to implement an “IPO subscription” strategy.
- Premia MSCI Vietnam ETF (09804.HK) advanced intraday, posting a nearly 80% gain over the past twelve months.
- Csop Ftse Vietnam 30 Etf (03004.HK) surged nearly 2.5%, while its underlying index has advanced more than 30% on a year-to-date basis.